Perma-Fix Environmental Services, Inc.

  • Market Cap: Micro Cap
  • Industry: Miscellaneous
  • ISIN: US7141572039
USD
13.87
1.62 (13.22%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Perma-Fix Environmental Services, Inc. stock-summary
stock-summary
Perma-Fix Environmental Services, Inc.
Miscellaneous
Perma-Fix Environmental Services, Inc. is an environmental and environmental technology know-how company. It operates in three segments: The Treatment Segment (Treatment), the Services Segment (Services) and the Medical Segment (Medical). Treatment includes nuclear, low-level radioactive, mixed (waste containing both hazardous and low-level radioactive waste), hazardous and non-hazardous waste treatment, processing and disposal services primarily through approximately four licensed and permitted treatment and storage facilities held by its subsidiaries. Services include on-site waste management services to commercial and government customers, technical services and nuclear services. The Medical segment includes research and development (R&D) of a new medical isotope production technology by its Polish subsidiary, Perma-Fix Medical S.A. (PF Medical). Its Treatment and Services provide services to research institutions, commercial companies, public utilities and governmental agencies.
Company Coordinates stock-summary
Company Details
8302 Dunwoody Pl Ste 250 , ATLANTA GA : 30350-3390
stock-summary
Tel: 1 770 58798981 212 6711020
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 19 Schemes (20.85%)

Foreign Institutions

Held by 20 Foreign Institutions (2.79%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Larry Shelton
Independent Chairman of the Board
Dr. Louis Centofanti
Executive Vice President - Strategic Initiatives, Director, President of PF Medical
Mr. Mark Zwecker
Lead Independent Director
Lt. Gen. (Retd.) Thomas Bostick
Independent Director
Mr. Joseph Grumski
Independent Director
Hon. Joe Reeder
Independent Director
Mr. Zach Wamp
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
15 Million
(Quarterly Results - Jun 2025)
Net Profit:
-3 Million
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

USD 225 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.35

stock-summary
Return on Equity

-32.40%

stock-summary
Price to Book

3.95